Clinical impact of the BCID2 and rapid AST VITEK® REVEALTM on antibiotic optimisation in critically ill patients with Gram-negative bloodstream infections: a quasi-experimental pre/post interventional study
The real-world implementation of RDT significantly shortened time to results but did not improve antibiotic therapy optimisation within 24 h of blood culture incubation. An antimicrobial stewardship programme could help enhance the clinical impact of RDT.
Authors
- Alix Pantel (ORCID: https://orcid.org/0000-0002-2317-4199)
- Claire Roger (ORCID: https://orcid.org/0000-0002-6055-0034)
- Adeline Dubois
- Florian Salipante (ORCID: https://orcid.org/0000-0002-5367-5058)
- Laurent Müller (ORCID: https://orcid.org/0000-0002-8788-179X)
- Jean-Philippe Lavigne
- Massinissa Benyahia
- Louis Oudiane
Institutions
- Inserm (FR)
- Université de Montpellier (FR)
- Université de Nîmes (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1093/jac/dkaf271
- Citations
- 5
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 6.59
Funders
- bioMérieux